Annual Report 2024/25 How your support is making a difference
|Contents||
|---|---|
|A word from...|4|
|The year in numbers|6|
|Enhancing patient care|8|
|Funding medical research|18|
|Supporting our staff|20|
|Hayward House Appeal|22|
|The Big Appeal|23|
|A gift in your Will can have a life-changing impact|24|
|Strategic report|26|
|Financial review|29|
|Structure, governance and management|34|
|Auditor’s opinion|44|
|Financial statements|48|
Welcome to Nottingham Hospitals Charity’s Annual Report 2024/25.
**We’re here to support patients, families, carers and staff at Nottingham’s NHS hospitals – including the City Hospital, Queen’s Medical Centre, Ropewalk House and Nottingham Children’s Hospital.**
Thanks to support from our generous donors, we’re able to fund enhancements to the hospital environment, state-of-the-art equipment, cutting-edge medical research, and staff wellbeing and development programmes.
None of this would be possible without the support of our incredible fundraisers and donors, from across the local community and beyond, who have helped raise over £4.2 million for Nottingham Hospitals Charity during 2024/25.
Read on to find out how people like you have been making a difference at Nottingham’s NHS hospitals.
3
**A WORD FROM OUR CHIEF EXECUTIVE, NIGEL GREGORY**
Welcome to our Annual Report, and thank you to every individual and organisation across the local community and beyond who helped us raise more than £4.2 million throughout 2024/25.
This was my first year as CEO of Nottingham Hospitals Charity, having been part of the Charity for over eight years. It was a year of change, with new staff members joining us across our fundraising, finance and communications teams, each bringing with them their own unique set of skills and experience.
As the Charity continues to grow, we hope to do even more to support patients, families and staff at our hospitals – with the help of our generous supporters, who give their time and money to help us in our aims.
Looking ahead to 2025/26 and beyond, I’m pleased to be leading the Charity in developing and implementing our new, three-year strategy. We will have a greater focus on garnering the support of the local community in fundraising for Nottingham’s hospitals, as well as working more closely with hospital staff to ensure the money we raise is used in the best possible way, with the greatest impact for patients and their loved ones.
In the meantime, please read on to find out more about some of the impactful projects that your donations have helped to fund.
Thank you once again to everyone who has supported Nottingham Hospitals Charity, and I look forward to seeing what we can achieve together in the coming year.
**A WORD FROM OUR CHAIR, CAROLE AYRE**
In this report, we are delighted to share with you some of the important and innovative projects your donations have helped to fund.
From local businesses who want to support their local NHS, to individuals and families who have been cared for and want to give back to Nottingham’s hospitals, we’re grateful for every donation.
As Chair of Trustees, I have the privilege of reviewing the grant requests that come into the Charity from our NHS colleagues at Nottingham’s hospitals. It is heartening to witness our NHS staff – who already work so hard to care for people from across the East Midlands and beyond – going above and beyond to find and recommend research projects, specialist equipment, and environmental enhancements which they know will have a positive impact on their patients.
Likewise, despite the cost of living crisis continuing to weigh on people across our community, we are extremely grateful to those who find ways to show their support for Nottingham Hospitals Charity – whether by making a donation, taking part in a fundraising activity, volunteering their time, or leaving a gift in their Will, to help patients in years to come.
In this report, you can read about some of the projects that your support has made possible. You can also find out about some of our ongoing appeals which you can support, and how to leave a lasting legacy by giving a gift in your Will to Nottingham Hospitals Charity.
Thank you for your valued support, and I hope you enjoy reading this report.
4
5
## The year in numbers
Total voluntary income: £3.7 million
Number of Total grants awarded: grants given: 662 £3.68 million
Largest grant: £999,000 for a surgical robot to aid surgical procedures at City Hospital
Number of donors and fundraisers: 2,368
Number of legacy gifts: 52
Smallest grant: £10.84 for a kettle to aid occupational health assessments before patients are discharged
Number of volunteers: 68
**6**
**7**
## Enhancing patient care
We know that nobody wants to spend time in hospital. But we’re here to help make hospital stays as calm and comfortable as possible, by providing more welcoming and less clinical facilities, engaging activities for patients young and old, and specialist eq uipment to aid diagnosis and treatment.
## Surgical robot
A new surgical robot is helping to make operations a smoother experience for patients at City Hospital, thanks to Wing Commander John Rodgers, who left a £1 million legacy gift in his Will.
The machine is the third of its kind at Nottingham University Hospitals (NUH) NHS Trust and together with the previously-installed machines, increased capacity from 300 operations a year in 2023, to over 750 in 2024.
Rachel Tomasevic, Directorate General Manager of Theatres, Anaesthesia and Perioperative Care at NUH, said: “Using a surgical robot makes procedures much more precise and less invasive, minimising the number of incisions, reducing injury and pain for the patient, and in turn leading to a q uicker recovery.
“This third robot has had a huge impact on the amount of surgery we’re able to do at NUH. The robot is used nearly every day, and our surgeons are always keen to be trained up on it and to use it as much as possible.”
None of this would have been possible without the generous gift Wing Commander John Rodgers chose to leave in his Will.
## Children’s sensory trolley
A new sensory trolley to help calm and distract children during hospital visits has been funded, thanks to supporters of our Big Appeal.
We gave almost £10,000 for the Rhino sensory trolley in Children’s Outpatients South at the Queen’s Medical Centre (QMC), to keep children occupied while having blood taken.
The trolley contains a variety of sensory activities, including a light-up bubble tube, tactile panels with soothing textures and musical instruments, a mirror ball, and an interactive projector where children can project jungle, circus or sea-themed images onto the ceiling.
Safa Mahfooz, Clinical Support Worker, said: “The Rhino trolley has made a big difference for our young patients, especially for children with special educational needs. It helps to calm and distract them, especially when having blood taken. In fact, they often don’t want to leave once they’ve started playing with it!”
Thank you to everyone who donated to the Big Appeal to help fund this impactful piece of eq uipment.
8
9
## Birthing pools for home births
## Clinic room
In 2024/25 we provided a suite of new birthing pools for the Homebirth team at Nottingham's hospitals.
The team was set up in March 2023, and supported 90 home births in its first year – 48 of which were water births. Thanks to our donors, we have been able to provide six out of the Homebirth team’s eight pools, supporting dozens of births across the city.
Joanne Moore, Assistant Practitioner for the Homebirth team, said: “Water has a huge impact as pain relief and reduces the amount of pharmaceutical options requested for birth. Being able to loan the pools also creates an equality for all birthing families, some who would consider it out of their financial scope.
“Birthing people should have the option to birth wherever they choose to, and the Homebirth team are able to offer personalised care plans to facilitate and achieve the best birthing experience.”
Thank you to everyone who donated to provide this special equipment for new parents and their newborn babies as they enter the world.
Thanks to our supporters, we funded a special clinic room for Harvey 2 Ward at City Hospital, which provides care for patients who have undergone breast and reconstructive surgery.
This unit is part of a ‘virtual ward’ scheme, which means patients can be sent home to recover in the comfort of their own home, but are closely monitored and receive followup appointments at the ward.
The new room allows people to be seen as outpatients during their recovery, rather than being admitted to the ward – meaning they can get back to the comfort of their own home much sooner.
## Family room on stroke ward
**----- Start of picture text -----**
10
**----- End of picture text -----**
An old consultation room on stroke ward C4 at QMC has been transformed into a calm and comforting area for family members who need to take a break from the busy ward environment.
Thanks to funding that we were able to provide, this quiet space is now available for families to step away from their loved one's bedside to take a breath, gather their thoughts and have sometimes difficult discussions with staff about their loved one's future.
**----- Start of picture text -----**
11
**----- End of picture text -----**
## Quiet room in Children’s Emergency Department
Thanks to our supporters, we have helped provide a much-needed quiet space in the busy Children’s Emergency Department (ED) at the Queen’s Medical Centre. We gave a grant for the creation of a new patient and visitor welfare room – named the Willow Room – which provides a safe and peaceful space for sensitive conversations.
Janice Morgan, Children’s ED Matron, explained: “We’ve seen quite an increase in children and young people needing mental health support over recent years, and they were previously having to be seen in quite clinical and busy spaces.
“So, we had the idea of creating a room where we could speak to children and young people about their mental health in a non-clinical area, in a calming environment that’s separate from the rest of the busy department.”
The Shared Governance team – which is a group of frontline staff who come together collaboratively, to make decisions and improvements in the area they serve – helped Janice get the project off the ground, and applied to Nottingham Hospitals Charity for funding.
A clinical room, which was rarely used due to it being set away from the main department, was identified as a suitable space. The funding we were able to offer helped to provide comfortable furniture and calming artwork for the new room.
Janice said: “I’m really happy with how it looks. The room has already been used for children and young people’s mental health assessments, and I think that it’s a much nicer environment for them, and encourages them to open up more.
“We also intend to use the room for difficult conversations with families. Sometimes we might have a really poorly child in our care, or need to break bad news to parents, so this room will be a space for those difficult conversations, away from the clinical environment and away from their child’s bedside.”
The Willow Room also has facilities for making hot drinks, which are not allowed in the main Children’s ED area due to the risk of burns. It means families going through a difficult experience can step away for a short while, make a hot drink, and gather their thoughts.
Janice said: “We’re so grateful to everyone who made this project possible – including everyone who has donated to Nottingham Hospitals Charity, and the Shared Governance team for getting this idea off the ground. We simply couldn’t have funded this room without the Charity’s support.”
**----- Start of picture text -----**
13
**----- End of picture text -----**
12
## Diagnostic eq uipment for Nottingham Breast Institute
A new piece of diagnostic equipment is helping ease anxiety and minimise the number of tests needed for patients awaiting a possible breast cancer diagnosis.
The contrast injector system, funded by a £16,320 grant from our Charity, is key to contrast-enhanced mammography. This is a technique designed to help ease some of the stress of awaiting diagnosis, by reducing the need for biopsies and, in some cases, MRI scans before a diagnosis is given.
Contrast injectors work by introducing a contrast dye into the patient’s bloodstream, which then helps highlight areas where the disease is or isn’t present during contrast-enhanced
mammography. Unlike traditional mammograms, this dye provides a more detailed view of breast tissue, improving visibility. This allows radiologists to detect the size and number of abnormalities more accurately, and reduces the risk of false negative results.
A key benefit of these specialist machines is reducing the need for further invasive procedures like MRIs or biopsies, which can increase patient anxiety. Contrast-enhanced mammography helps confirm or rule out breast cancer, sparing many from additional stress.
## Art projects at Hayward House
Arts and crafts activities have been bringing joy, creativity and a sense of community for terminally ill patients at Hayward House palliative care centre.
Thanks to our donors, we fund a range of art and craft activities for outpatients attending the Day Therapy service at Hayward House – including painting, drawing, sculpting and printmaking.
Paul Lillie, Artist in Residence at Nottingham’s hospital, whose visits are funded by our donors, said: “Art can be a powerful distraction – something to focus on that’s positive and absorbing. The sessions also encourage conversation, which helps to build a real sense of community among those who attend Day Therapy regularly.
“I don’t always arrive with a set plan – sometimes ideas emerge naturally from group conversations, and I just follow their lead. Art is a brilliant way to spark human connection and create a warm, welcoming atmosphere where people can truly be themselves.”
The Nottingham Breast Institute was among the first in the UK to use this equipment and has since participated in a national study on breast screening with contrast-enhanced mammography.
Thanks to donations, this state-of-the-art equipment is making a significant difference to patients during times of high anxiety and uncertainty.
14
15
## Children’s research facility
We funded a range of enhancements to make the new Children’s Clinical Research Facility at Queen’s Medical Centre more child-friendly and welcoming for young patients.
Donations helped to fund artwork, toys and games at the research centre, to help children feel more at ease while taking part in important medical research studies.
Louise Paine, Children's Clinical Research Facility Operations Manager, said: “This funding has made a significant difference to both staff and patients. The unit feels fresh and new for staff, and for children it feels welcoming.
“It is important to remember that the majority of these children are coming here voluntarily. They don’t have to take part in a research trial if they don’t want to. So, it’s particularly important to have a welcoming environment – it makes them feel safe and makes them want to come back; the children feel like they have something to do while they’re in the unit that’s appropriate for them and that not all of it is about medical intervention.”
Thank you to everyone who has donated to make projects like this possible.
16
17
## Funding medical research
At Nottingham Hospitals Charity, we are passionate about investing in local medical research, enabling the clinicians at our hospitals to be at the cutting edge in developing new treatments and methods of diagnosis for a wide range of conditions.
## Impact of glaucoma surgery
We gave £24,735 for a study investigating the potential impact of glaucoma surgery on patients. Researchers at Nottingham’s hospitals are investigating how best to measure the everyday impact of complications that can arise from glaucoma surgery, and how best to convey this information to future patients in the most helpful and meaningful way.
## Diagnostic tests for bacterial infection
We granted £4,051 for equipment to support the development of new diagnostic tests for bacterial infection.
The study aims to help tackle the global issue of antibiotic resistance, by developing quick and accurate tests to determine whether an infection is bacterial, and therefore whether antibiotics should be prescribed, or whether other treatment options are more appropriate.
## Cardiac research
We gave £56,782 for research into cardiac scarring following a heart attack, which is the most common cause of life-threatening heart rhythm disorders.
The research team at Nottingham’s hospitals hopes to find ways to improve identification of patients who may be at risk, ultimately leading to better outcomes and fewer cardiac deaths.
18
19
## Supporting our staff
We know that caring for the incredible team of staff at Nottingham’s NHS hospitals can have a positive impact on patient care as well. We’re committed to supporting the wellbeing and development of over 19,000 staff at Nottingham’s hospitals, helping them to be the best that they can be, for the patients they treat.
## Eye casualty training eq uipment
We granted £9,120 for laser training equipment for the eye casualty department at QMC. Retinal lasers are used to treat retinal tears and other conditions, which can be a daunting prospect for trainee staff.
The funding we were able to provide will allow a teaching screen to be used alongside the laser, to help train new staff. The screen will enable them to better see how and where to use the retinal laser, and give them greater confidence to ultimately carry out this skilled procedure themselves.
## Expressing chairs
We’re helping new mums return to work by equipping two new expressing rooms at the City Hospital and QMC with special expressing chairs.
We gave £647 for two expressing chairs – one for each room – to give parents a comfortable place to sit while expressing, enabling them to continue providing breastmilk for their child, while also returning to work.
The rooms have been created thanks to the Staff Wellbeing team, after staff requested a private, dedicated space to express and store breastmilk for their babies.
## Outdoor space
We gave £2,836 to revamp an outdoor space so that hospital staff can get some fresh air during their breaks from busy shifts.
The Leengate building on the QMC campus opened in October 2023, and delivers outpatients clinics to over 10,000 patients per year. We gave funding to provide outdoor seating in the building’s courtyard area, which can be accessed by staff. The new seating means they can step away from the busy clinic environment during breaks, take a short rest, and return refreshed to continue their care of patients.
20
21
## The Big Appeal
## Hayward House Appeal
In December 2024, we were delighted to be involved in the opening of the new Neonatal Unit at the QMC.
Thanks to supporters of our Hayward House Appeal, the revamped garden at Hayward House palliative care unit was officially opened in September 2024.
The enhanced garden is now more accessible for patients and visitors – allowing them time and space away from the hospital environment.
The £32 million unit is the largest in the East Midlands, and is four times the size of the previous Neonatal Unit at the hospital. It was specially designed to be a home-from-home for babies and their families, who may spend weeks or even months in hospital.
The funding given through the Hayward House Appeal helped create new pathways so that patients in wheelchairs and beds can now access this peaceful area.
Thanks to supporters of our Big Appeal, we were able to provide over £322,000 of funding to provide family-friendly enhancements to the unit. This includes welcoming artwork, comfortable furniture, and children’s play equipment, to help make the unit less daunting for families spending time there, as well as glazed screens between bays, to allow families space and privacy with their babies.
As the appeal continues, work on the next phase of development started in May 2025. This next phase of improvements will focus on making the main entrance and reception area more welcoming and homely for patients and their loved ones, at what may be a very difficult time.
A special thanks goes to our Big Appeal ambassadors, England cricket legend Stuart Broad and his mum Carole Joyce, and to Mowgli restaurant in Nottingham, who have raised more than £95,000 over the past eight years by adding a discretionary £1 donation to every meal.
Sarah Radcliffe, Head of Service for Specialist Palliative Care at Nottingham hospitals, said: “We know that arriving at Hayward House can feel daunting. That’s why we’re focusing on transforming the entrance and reception to feel less clinical and more like home – a place of warmth and dignity, not fear."
To support the Hayward House Appeal, please visit www.nottinghamhospitalscharity.org.uk/haywardhouse
To support the Big Appeal, please visit - www.nottinghamhospitalscharity.org.uk/big appeal
22
23
## A gift in your Will can have a life-changing impact
Behind every legacy gift is a story - whether it is to honour the care a loved one has received, to express gratitude for your own treatment, or simply to support your local hospitals for generations to come.
A gift in your Will can change the lives of patients and families at Nottingham’s NHS hospitals.
We would like to thank everyone who has pledged a gift in their Will. These gifts make up a third of our donations. They are truly transformational. They allow us to plan for the future, in which Nottingham’s NHS hospitals will continue to change people’s lives and provide the best care possible.
If you are thinking of writing a new Will, or want to update your Will, we offer a free online Will-writing service through our charity partner, My Intent. Simply visit www.nottinghamhospitalscharity.org.uk/will or call us directly for more information on 0115 962 7905.
Every gift, large or small, can make a lifechanging difference. Thank you for considering supporting Nottingham Hospitals Charity in this incredible way.
**24**
**25**
## Strategic report
## Charity update: Achievements and performance
Nottingham Hospitals Charity exists to support patients, families and staff at Nottingham University Hospitals (NUH) NHS Trust.
We work closely with our supporters and with NUH staff to raise money and give grants to fund the most impactful projects across our hospitals.
## 4. Increase our profile and visibility within NUH Trust at all levels to enhance our relationships and support our mission to enhance patient care and transform hospital services. **This is an ongoing goal and requires continuous effort. Success is evident in our relationships across the organisation.**
5. Implement appeal plans for Maternity and Neonatal Redesign (MNR) and develop appeal plans for the Cancer Care Appeal (both Trust dependent). **The MNR appeal and works are complete. The Cancer Care Appeal development is in its early stages.**
## **Plans for future periods: 2025/26 (continuation of three-year strategy)**
With the support of the local community, and working alongside our NUH colleagues, we have been able to provide a huge range of enhanced environments, state-of-the-art medical equipment, cutting-edge research and staff support programmes.
## **Our charitable objectives and activities**
## **The Charity’s objects are underpinned by our commitment to improving the patient experience and are furthered by such charitable purposes relating to:**
Creating a caring environment for all who use Nottingham’s hospitals
1. Raise voluntary income of £3,074,000 through various fundraising, communications, marketing and profile-building activities. To deliver on our grant-making ambitions, support NUH’s strategic priorities, and realise our own fundraising goals, we are aiming to increase annual income to £6 million by 2027/28.
2. Implement the Grant Strategy to enable us to better focus our giving in key target areas and align more with NUH Trust priorities.
Investing in staff wellbeing and development projects
Purchasing the newest technology
3. Launch a Nottingham Hospitals Charity Lottery.
Funding local research and innovation
## **We will facilitate these objects through:**
4. Develop closer relationships with NUH staff at every level to support our mission to enhance patient care and transform hospital services.
Inspiring fundraising appeals
Carefully considered grant-making programmes
Working with our hospitals and clinical staff as well as the communities we serve
5. Make Nottingham Hospitals Charity an outstanding place to work - we are focusing on recruiting and retaining the best talent for our Charity by creating a culture and ethic in which individuals and teams can thrive.
## **Review of 2024/25 objectives**
## **And beyond**
1. Raise voluntary income of £2,611,000 through various fundraising, communications, marketing and profile-building activities. **This was achieved, raising voluntary income of £3,741,000.**
2. Develop a 3-year Grant Strategy to enable us to better focus our giving in key target areas and align more with NUH Trust priorities. **The Grant Strategy has been developed and is progressing through a consultation exercise with NUH Trust board and staff.**
3. Complete the final stage of fundraising for the Hayward House Appeal. **At the time of writing, we have raised £1.26 million. Building work on the final phase of the project is now in progress and is due to be completed by October 2025.**
Our charity strategy for 2025–2028 is built around four key aims that will strengthen our organisation and increase the positive impact we make.
In the years ahead, we will focus on:
## Expanding our fundraising capabilities
Deepening our partnership with our main stakeholder, Nottingham University Hospitals NHS Trust (NUH), and its 19,000 staff
Rebuilding and growing our team
- Implementing our Grant Strategy to support Nottingham’s NHS
26
27
## **Principal objectives and aims**
Our **vision** is to create the best possible NHS care and facilities at Nottingham University Hospitals NHS Trust, to benefit the people of the East Midlands and beyond.
Our **mission** is to enhance treatment and facilities for patients, families, carers and staff, by supporting Nottingham University Hospitals NHS Trust in providing world-class care, research and innovation. We will work with staff at the hospitals, and patients and supporters across the local community, to provide improved environments, state-of-the-art medical equipment, cutting-edge research and staff support programmes. We will involve people from across the local community in fundraising for their local hospitals, and will work with hospital staff to ensure the money we raise is used in the best possible way, with the greatest impact for patients and their loved ones, and for the people who work there.
## Financial review
The accounts and annual report are prepared to comply with both the Companies Act 2006 and the Charities Act 2011.
Overall, the assets of the Charity at 31 March 2025 were £16.918 million, compared to £16.880 million in 2023/24 – an increase of £38,000.
**Total expenditure: £4.281 million (2023/24: £3.170 million).**
**Total income: £4.209 million (2023/24: £3.526 million).**
## **Total income**
Overall income in 2024/25 increased to £4.209 million compared to £3.526 million in the previous financial year. The main reason for this was an increase in legacy gifts.
Donation income during 2024/25 was £1.173 million, which was considerably less than the previous year (2023/24: £1.849 million). This decrease was mainly due to a significant donation of £771,715 from the City Hospital Research Charity in 2023/24, which closed and transferred its assets to our pump-priming research programme.
Legacy income was higher in 2024/25 at £2.359 million (2023/24: £987,000). This was largely due to a legacy of £1.1 million from Wing Commander John Rodgers, which funded a surgical robot, along with other legacy gifts.
Investment income reduced to £468,000 (2023/24: £548,000).
## **Charitable expenditure**
Total charitable expenditure for 2024/25 was £3.533 million, compared to £2.284 million in the previous year – an increase of £1.249 million. The main reason for the increase was the grant for the surgical robot funded from the legacy of Wing Commander John Rodgers, at a cost of £999,000. We also granted £322,000 through our Big Appeal, for enhancements to the new Neonatal Unit at the Queen’s Medical Centre.
Last year we reported a marked decline in research projects, but this year we gave £288,000 to support local medical research, compared to £83,000 in 2023/24. Grants included £56,782 for research into cardiac scarring.
28 **28**
29
**Ethical investment and sustainability**
There is an increasing trend towards a higher number of smaller grants, particularly in relation to staff wellbeing and development, with 117 additional grants in this area compared to the previous year.
We continue to work closely with staff across our hospitals to identify and support projects which will have the greatest impact for patients, families and staff.
In 2024/25 the Charity gave 662 grants (2023/24: 545) in total, in areas as detailed below:
|EXPENDITURE||2024/25||2023/24|
|---|---|---|---|---|
|||£000||£000|
|Patient welfare and amenities||2,277||1,229|
|Staff welfare and development||250||310|
|Research||288||83|
|Building and refurbishment||194||116|
|**Total grant expenditure**||**3,009**||**1,738**|
|Fundraising costs (including
investment management fees)||748||886|
|Support costs and governance||524||546|
|**Total expenditure**||**4,281**||**3,170**|
To ensure that we are providing the best support possible to NUH we work closely with clinicians and management to identify projects that align with NUH priorities. To increase and focus grant-making we developed a new Grants Strategy during 2024/25 to ensure the best use of Charity funds. At the time of writing, a planned consultation with staff at NUH was ongoing, with a view to introducing the strategy in quarter 3 of 2025/26.
## **Grant-making policy**
The Charity fulfils its objects by awarding grants to Nottingham University Hospitals NHS Trust for the benefit of patients, staff and visitors.
## **Investment policy**
Funds that are not required for
immediate expenditure are invested in a balanced portfolio. Recognising the need for growth and the demands on the Charity’s charitable income, the Trustees recognise that its investments must be protected from market volatility and subsequent risk to its assets.
## **For this purpose, the Charity has an investment policy, the objectives of which are:**
- To enhance the real value of capital over time whilst generating a reasonable level of income.
- To generate income to meet the charitable requests made to us, and Charity support costs.
## **The Trustees recognise the need to be protected against market conditions and, within this volatile market, the policy states:**
- Hold expenditure for shorter-term grants in cash deposits. The Charity will draw down cash from investments in line with planned expenditure for shorter term projects or priority needs. Appeal funds are held in fixed-term treasury accounts.
- A percentage of the value of the investment portfolio is held in reserve. Advice from the Charity’s investment advisors is received regularly with attendance at Trustee meetings at least twice annually.
The primary objective is to ensure the long-term financial sustainability of the Charity. However, the Trustees also wish the portfolio to recognise the Charity’s wider responsibilities to society and as such, environmental, social and governance (‘ESG’) factors are considered when allocating capital. Investment managers are expected to:
- embed ESG considerations into their investment decision-making process; exclude holdings which are seen to be in conflict with the Charity’s purpose and broader view on ESG issues; and consider the values and reputation of the Charity when making investment decisions.
In addition to these guidelines, direct investments in tobacco manufacturers are not permitted.
At 31 March 2025 the total value of our investments was £16.222 million, which represented a decrease of £2.080 million in the year (2023/24: £18.302 million). This comprised a transfer to deposit accounts of £2.0 million, with the remainder being a loss on the portfolio (after fees).
Investment income was £468,000, which represented a decrease of £80,000 compared to the previous year (2023/24: £548,000).
Grants are awarded to develop new services and innovative ways of improving patient care, including capital projects, innovation and technology, local research and staff development projects. The Charity awards grants from both restricted and unrestricted funds. Many of the funds are earmarked for particular wards or specialities. Expenditure up to £2,500 is overseen by fund advisors, who are usually clinicians, under delegated powers. Expenditure above this level is approved by Charity executive officers and Trustees.
30
31
## **Reserves policy**
The Charity Trustees wish to provide long-term support to Nottingham University Hospitals NHS Trust.
## **The policy states:**
The Charity Trustees recognise their obligation to ensure that funds received should be spent effectively and promptly in accordance with the Charity’s objects. However, it is considered prudent that a workable level of reserves be maintained to protect the continuity of the Charity’s work in the event of a shortfall in income and to minimise risk to projects.
The minimum reserves level is set at £1.0 million and is sufficient to fund one year’s Charity operating costs. It is based on:
Costs of governance
- Costs of fundraising activity to generate funds to ensure the stability of grant funding to Nottingham University Hospitals NHS Trust.
This will allow the Charity to respond to any adverse change in circumstances and develop plans without the need for an urgent response.
The Charity receives both restricted and unrestricted income from donations, legacies, fundraising events and grants. Whilst the restricted income is greatly valued in supporting specific projects at the hospitals, unrestricted income remains crucially important. We believe that clinicians know what is best for their patients, and unrestricted income enables us to support such enhancements which have the greatest impact on patient care.
## **Funds include:**
- Restricted funds: **£2.186 million** (2023/24: £1.755 million). These are funds that are subject to legal restriction and do not form part of reserves.
- Designated funds: **£12.989 million** (2023/24: £13.657 million). These are funds where the income has been given for a specific ward/department/research at NUH Trust and which are earmarked for specific future spending; these funds are excluded from reserves.
The value of Charity reserves at 31 March 2025 was **£1.743 million** (2023/24: £1.468 million).
The level of reserves is monitored at quarterly Trustee meetings throughout the year, and reviewed annually.
32
33
**Trustees during the year 2024/25 were:**
## Structure, governance and management
On 1 February 2016 Nottingham University Hospitals Charity reconstituted as an independent charity (No 1165397) regulated by the Charity Commission (originally formed on 7 November 2006). The Charity is incorporated as a company limited by guarantee (No 09978675) and donations, legacies and fundraising income received by us are strictly separated from NHS finances. Our objects set out in the Articles of Association are to apply income for any charitable purpose or purposes relating to the purposes of the Nottingham University Hospitals NHS Trust or any purposes relating to the National Health Service.
## Our Trustees
Trustees, who are also directors for the purposes of company law, have full responsibility for the Charity’s governance and are accountable to the Charity Commission.
Each Trustee has independent expertise that ensures effective coverage in a broad range of areas: law, accounting, economics, medical, business management and leadership.
Under the Articles of Association new Trustees are elected by the Trustees for a term of up to four years. An outgoing Trustee may be re-appointed, but no individual Trustee may serve more than 10 years in total unless the Trustees consider there to be exceptional circumstances. Nottingham University Hospitals NHS Trust has the right to appoint one Trustee to the Charity.
New Trustees receive appropriate induction on their responsibilities and are issued with detailed induction information. Trustees receive an annual appraisal from the nominated Chairman of the Trustees. Trustees are recruited through an open process that is publicly advertised as well as through a specialist recruitment agency.
## **Carole Ayre, Chair**
## **(In position 1 March 2017 – present)**
Carole is a retired partner at law firm Browne Jacobson and led the development of their NHS Clinical Negligence team. Her focus was on promoting the development of health law practice at the firm, and she has brought with her a wide range of experience within the NHS sector.
## **Laurence Coppel**
## **(In position 1 February 2016 – 3 September 2024)**
An economist and chartered accountant, past Non-Executive Director of Queen’s Medical Centre (1993 to 1999) and Chairman of Nottingham Building Society until 2004. He was a founder Trustee of our Charity as an independent Charity. He was a sound advisor and supporter to us throughout his tenure as a Trustee.
## **Roger Whittle**
## **(In position 1 April 2016 – present)**
Nottingham-born Roger is the founder and CEO of Nottingham IT solutions company Jigsaw24, employing over 300 people across the UK, with annual sales of over £150 million. Roger established Jigsaw24 in 1992 and has been a Trustee of the Charity since 2016. Roger’s daughter Rose Whittle received excellent care from 2011 to 2013 at Nottingham Children’s Hospital in her ultimately unsuccessful fight against cancer.
## **Harish Vyas**
## **(In position 1 April 2017 – 21 May 2024)**
Harish’s medical career spans four decades and includes working at Great Ormond Street. At Nottingham he brought together children’s units from the former City and QMC hospitals to form Nottingham Children’s Hospital, and led the Paediatric Intensive Care Unit. Harish also brought a strong research background with him.
## **Mark King**
## **(In position 1 November 2018 – present)**
Mark spent 27 years in the aerospace industry with Rolls-Royce plc in the UK, ultimately becoming President of Aerospace – a division with £8.5 billion of sales, 27,000 employees and global operations. Since leaving Rolls-Royce in 2013 Mark has worked with a number of smaller venture capital backed companies providing non-executive and ‘semi-executive’ support. Mark is currently Chairman of three companies - DEA Aviation Ltd, a provider of aerial survey and surveillance services; Bowman Power Group, a high speed electrical machines manufacturer and Alloyed Ltd, a specialist in digital alloy design and additive manufacturing.
34
35
## **Roger Summerton**
## **(In position 1 February 2020 – present)**
Roger joined the Charity in February 2020. He is a chartered accountant and spent 45 years in the accounting profession, 20 of which were as a partner at KPMG. In more recent years Roger has been a director of a local financial advisory business and the director of a family office.
## **Keith Girling**
## **(In position 24 May 2021 – 21 May 2024)**
Keith is a former consultant in critical care medicine and former Medical Director at NUH. Having worked at NUH for over 30 years, he was instrumental in supporting the Charity to make a significant impact during his tenure.
## **Sanjeev Sharma**
## **(In position 1 April 2022 – 20 May 2024)**
Sanjeev joined our Board of Trustees after previously supporting the Charity and raising more than £42,000 through a Mount Snowdon trek, to thank hospital staff for saving his life after he was seriously ill with Covid19. Sanjeev is a successful and well-respected barrister, based in Nottingham but practising across the country.
## **Ilana Freestone**
## **(In position 1 September 2022 – present)**
Ilana is CEO of local charitable trust Active Partners Trust, which aims to empower everyone in the community to be active. She helped establish the Trust in 2017, setting up all aspects of governance and recruiting a new Board and team.
## **Paul Matthew**
## **(In position 3 September 2024 – present)**
Paul joined Nottingham University Hospitals (NUH) NHS Trust in May 2023 as Chief Financial Officer. He is our link Trustee between the Charity and NUH Trust, and is keen to further develop the relationship between the Trust and the Charity to maximise the impact on patients and staff at NUH.
## **Dr Judith Grant**
## **(In position 26 November 2024 – present)**
Dr Grant is a retired consultant neonatologist, having spent 24 years as part of the Nottingham Neonatal service at the Queen’s Medical Centre. During this time, she also developed a keen interest in postgraduate medical education within both NUH and the wider East Midlands Deanery, where she held the position of Training Programme Director in Paediatrics for 10 years.
## **Sir David Greenway**
## **(In position 26 November 2024 – present)**
Sir David served as Vice Chancellor of the University of Nottingham for almost a decade until 2017, having previously been a Pro-ViceChancellor and Professor of Economics. His public appointments include Chair of the Armed Forces Pay Review Body; Member of the Senior Salaries Review Body; Advisor to the World Bank and United Nations; and National Health Service Board appointments. Sir David received a knighthood for services to higher education and public policy in 2014.
## Public benefit
The Trustees confirm that they have complied with the Charity Commission’s general guidance on public benefit. The projects funded by the Charity support benefits to patients, staff and visitors using healthcare facilities of Nottingham University Hospitals NHS Trust in line with donors’ wishes and the Charity’s mission and objectives.
## **Nigel Gregory**
## **Chief Executive**
Nigel became CEO of Nottingham Hospitals Charity in 2024, after joining the Charity as Director of Development in 2016. He has more than 25 years’ experience in fundraising across the UK and USA. In his role as CEO, Nigel is responsible for overseeing all fundraising and granting activities, and developing and implementing the Charity's three-year strategy.
## **Julie Brailsford**
## **Director of Finance/Deputy CEO**
Julie is a qualified accountant and has dedicated most of her career to financial management and financial services in the NHS. Julie has worked at the Charity since 2008 and is responsible for the overall management of the Charity’s finance and governance arrangements, ensuring that income and expenditure are properly accounted for and donations are used where they are intended and needed within Nottingham University Hospitals NHS Trust.
## **Sam Cousens**
## **Director of Fundraising and Communications (In position from 4 November 2024)**
Sam joined the Nottingham Hospitals Charity team in 2024, having worked for a range of arts, heritage and further education organisations. Sam is passionate about the NHS and also about Nottingham. She leads the Charity’s fundraising and marketing and communications team.
36
37
## Remuneration Statement
Our Charity’s remuneration policy is reviewed by our Trustees annually. It is to offer nondiscriminatory, fair, reasonable and competitive pay to attract and retain appropriately qualified, experienced and professional staff to lead, manage and deliver the Charity’s objectives. In setting this policy, the Trustees consider pay policies and practices in comparable charitable organisations, regionally and nationally.
In 2024/25, the Charity employed 17 full-time equivalent staff. Two employees received total remuneration greater than £60,000. The multiple between the highest pay and the median pay was no more than 3.5 times.
## Managing risks
## **The Trustees are legally required to minimise significant risks to the Charity. The key risks to the Charity in 2024/25 were:**
**Cyber risk:** Cyber insurance has been purchased and staff receive annual cyber security training.
**Inflation:** The Charity’s running costs are closely monitored with authorisation processes in place to review spending.
**Volatile investments:** Regular investment reviews are conducted by Trustees following this changing financial environment through the year.
The risk register is reviewed quarterly at Trustee meetings and all major risks have been reviewed.
## Fundraising
We are compliant with the most recent changes in fundraising regulations and data protection legislation. We are registered with both the Information Commissioner’s Office and the Fundraising Regulator and have adopted the Fundraising Promise.
All activities are monitored closely by the senior management team, and the Trustees review the potential risks of the Charity at each meeting, with established systems to ensure appropriate controls are in place.
Working practices and procedures are carried out in line with guidance from the Charity Commission, Institute of Fundraising, Information Commissioner’s Office and Fundraising Regulator. We use the services of external auditors to review the compliance with these regulatory bodies.
## Statement of Trustees’ responsibilities
The Charity Trustees (who are also directors of Nottingham University Hospitals Charity for the purposes of company law) are responsible for preparing the Trustees' Annual Report (including the strategic report) and the financial statements in accordance with applicable law and regulations.
Company law requires the Trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the Charity under company law. The Trustees must not approve the financial statements unless they are satisfied that, to the best of their ability and knowledge, they give a true and fair view of the state of affairs of the charitable company and of the income and expenditure for that period.
In preparing these financial statements to the best of their ability, the Trustees are required to:
- select suitable accounting policies and then apply them consistently;
- observe the methods and principles in the Charities SORP (FRS 102);
- make judgements and estimates that are reasonable and prudent;
- state whether the financial statements comply with applicable accounting standards and statements of recommended practice, subject to any material departures disclosed and explained in the financial statements; prepare the financial statements on a going concern basis unless it is inappropriate to presume that the charitable company will continue its activities.
The Trustees are responsible for keeping adequate accounting records that disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and for taking reasonable steps to prevent and detect fraud and other irregularities.
The Trustees are responsible for the maintenance and integrity of the corporate and financial information included on the charitable company’s website. Legislation in the UK governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.
In so far as Trustees are aware:
- There is no relevant information being needed by the company’s auditor in connection with preparing their audit report of which the auditor is unaware. The Trustees have taken all steps that they ought to have taken to make themselves aware of any relevant audit information and to establish that the company’s auditors are aware of that information.
This report has been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies and with the Statement of Recommended Practice, Accounting and Reporting for Charities (FRS102).
By Order of the Board of Trustees **Chair: Trustee:**
Name: Carole Ayre Name: Roger Summerton Date: 02/09/2025 Date: 02/09/2025
38
39
**----- Start of picture text -----**
40
**----- End of picture text -----**
## Fundraising activities
## Fundraising
## Fundraising promise
We are active across the fundraising spectrum and offer existing and potential supporters a broad range of ways to support us, including a variety of events, in-memory giving, regular giving, leaving gifts in Wills, corporate and community engagement programmes, staff fundraising, and trusts and foundations.
As a charity, we believe people need to feel that we are using our resources effectively. That is why we make these fundraising promises:
- We promise to provide information about our work and our finances so everyone can see how their money is being spent and the difference they are making to the patients and staff looking after them at Nottingham’s hospitals.
We do not rely on the services of any external professional fundraising partners.
- We promise to communicate with supporters in a way that suits them. If they tell us they would prefer less contact or do not want us to hear from us at all, we will respect their wishes.
Our fundraising costs as a percentage of the income generated were 17% in 2024/25 (down from 27% in 2023/24). This lower percentage is partly due to the higher level of voluntary income in 2024/25, but also to a high turnover of staff in 2024/25. We continue to invest in fundraising and marketing, to maximise income and remain poised for future growth in the economy.
We promise never to sell an individual’s data to any third party. We will not share their details with other charities.
- We promise to adhere to all industry guidelines and regulations. We promise to make it easy for individuals to tell us their contact preferences and we are here to talk about our work or answer any uestions.
## Complaints
We report our complaints to align with the Fundraising Regulator req uirements. The number of complaints received for the 12 months to 31 March 2025 regarding fundraising was zero (2023/24: zero).
We promise to treat all our supporters, and anyone who contacts us regarding fundraising or donating, with respect, and to uphold their right to privacy.
## Vulnerable persons
We have a vulnerable persons policy in place to protect people in vulnerable circumstances.
**41**
## Volunteering
The Charity was supported by 68 volunteers during 2024/25, representing a 323% increase in volunteering hours compared to the previous year.
Volunteers help with a range of important tasks at the Charity, including attending fundraising events to act as stewards, attending cheque presentations to meet and thank donors, and serving customers in our Charity Hub and shop at the Queen’s Medical Centre.
Volunteers from a number of local businesses and organisations also supported our annual Christmas tree recycling scheme, freely giving their time and vehicles to collect and recycle trees from across Nottinghamshire.
We are extremely grateful to all our volunteers, who support the work of Nottingham Hospitals Charity.
**----- Start of picture text -----**
43
**----- End of picture text -----**
**42**
## Auditor’s opinion
Independent Auditor's report to the Members of Nottingham University Hospitals Charity.
## **Opinion**
## further described in the auditor
responsibilities for the audit of the financial statements section of our report. We are independent of the charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
We have audited the financial statements of Nottingham University Hospitals Charity (the ‘charitable company’) for the year ended 31 March 2025 which comprise of the statement of financial activities, balance sheet, statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
## **Conclusions relating to going concern**
In auditing the financial statements, we have concluded that the trustees’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
In our opinion the financial statements:
• give a true and fair view of the state of the charitable company’s affairs as at 31 March 2025, and of its incoming resources and application of resources, including its income and expenditure, for the year then ended;
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charitable company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
- have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.
- have been prepared in accordance with the requirements of the Companies Act 2006.
## **Basis for opinion**
## **Other information**
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are
The other information comprises the information included in the trustees' annual report, other than the financial statements and our auditor’s report thereon.
The trustees are responsible for the other information. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
## **Opinions on other matters prescribed by the Companies Act 2006**
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the report of the trustees (incorporating the directors’ report) for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the trustees’ report has been prepared in accordance with applicable legal requirements.
## **Matters on which we are required to report by exception**
In the light of the knowledge and understanding of the charitable company and its environment obtained in the course of the audit, we have not identified material misstatements in the trustees' report.
We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of trustees’ remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit: or
- the trustees were not entitled to prepare the financial statements in accordance with the small companies’ regime and take advantage of the small companies’ exemptions in preparing the Report of the Trustees and from the requirement to prepare a strategic report.
## **Responsibilities of trustees**
As explained more fully in the trustees’ responsibilities statement set out on page 39, the trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, the trustees are responsible for assessing the charitable company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to
44
45
liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.
## **Auditor responsibilities for the audit of the financial statements**
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below.
Our assessment focussed on key laws and regulations the charitable company has to comply with and areas of the financial statements we assessed as being more susceptible to misstatement. These key laws and regulations included but were not limited to compliance with the Companies Act 2006, Charities Act 2022, Charities (Protection and Social Investment) Act 2016, taxation legislation, data protection, anti-bribery and employment legislation.
We are not responsible for preventing irregularities. Our approach to detecting irregularities included, but was not limited to, the following:
- obtaining an understanding of the legal and regulatory framework applicable to the charitable company and how the charitable company is complying with that framework, including agreement of financial statement disclosures to underlying documentation and other evidence;
- obtaining an understanding of the charitable company’s control environment and how the charitable company has applied relevant control procedures, through discussions with Trustees and other management and by performing walkthrough testing over key areas;
- obtaining an understanding of the charitable company’s risk assessment process, including the risk of fraud;
- reviewing meeting minutes of those charged with governance throughout the year; and
- performing audit testing to address the risk of management override of controls, including testing journal entries and other adjustments for appropriateness, evaluating the business rationale of significant transactions outside the normal course of business and reviewing accounting estimates for bias.
Whilst considering how our audit work addressed the detection of irregularities, we also considered the likelihood of detection based on our approach. Irregularities arising from fraud are inherently more difficult to detect than those arising from error.
Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.
A further description of our responsibilities is available on the Financial Reporting Council’s website at:
www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.
## **Use of our report**
This report is made solely to the charitable company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and the charitable company’s members as a body, for our audit work, for this report, or for the opinions we have formed.
## **Glen Bott FCA**
Senior Statutory Auditor for and on behalf of:
## **Cooper Parry Group Limited**
Statutory Auditor, Sky View, Argosy Road, East Midlands Airport, Derby DE74 2SA
46
47
Financial statements
## Statement of Financial Activities
## for the year ended 31 March 2025
## Balance sheet
## as at 31 March 2025
(Incorporating an Income and Expenditure Account)
|Statement of Financial Activities
for the year ended 31 March 2025
(Incorporating an Income and Expenditure Account)|Statement of Financial Activities
for the year ended 31 March 2025
(Incorporating an Income and Expenditure Account)|Statement of Financial Activities
for the year ended 31 March 2025
(Incorporating an Income and Expenditure Account)|es|
|---|---|---|---|
|2024/25
2023/24
Note
Unrestricted
Funds
£000
Restricted
Funds
£000
Endowment
Funds
£000
Total
Funds
£000
Unrestricted
Funds
£000
Restricted
Funds
£000
Endowment
Funds
£000
Total
Funds
£000
Income and endowments from:
Donations and legacies
2
1,611
1,921
0
3,532
2,053
783
0
2,836
Charitable Activities
3
0
0
0
0
0
0
0
0
Other trading activities
4
209
0
0
209
142
0
0
142
Investments
5
423
45
0
468
525
23
0
548
Total income and endowments
2,243
1,966
0
4,209
2,720
806
0
3,526
Expenditure on:
Raising Funds
535
117
0
652
732
60
0
792|||2023/24
Unrestricted
Funds
£000
Restricted
Funds
£000
Endowment
Funds
£000
Total
Funds
£000|
||||2,053
783
0
2,836
0
0
0
0
142
0
0
142
525
23
0
548|
|Total income and endowments|2,243|||
|Expenditure on:
Raising Funds|535||732
60
0
792|
|Investment Management costs
Sub total
6
Charitable Activities:
Patient Welfare and Facilities|85|11
0
96
83
11
0
94
128
0
748
815
71
0
886
1,398
0
2,672
1,273
342
0
1,615|83
11
0
94|
||620
1,274|||
|Staff Welfare and Development|275|19
0
294
406
1
0
407||
|Research
Building & Refurbishment
Total Charitable Expenditure
8|339
228|0
0
339
0
0
228
1,417
0
3,533|109
0
0
109
153
0
0
153|
||2,116||1,941
343
0
2,284|
|||1,545
0
4,281
421
0
(72)
12
0
110||
|Total expenditure|2,736||2,756
414
0
3,170|
|||||
|Net income/(expenditure) before gains/
(losses) on investments|(493)||(36)
392
0
356|
|Gains/(Losses) on investment assets
12|98||863
118
0
981|
|||433
0
38||
|Net income/(expenditure)|(395)||827
510
0
1,337|
|||(2)
0
0
2
45
(47)
0||
|Transfers between funds
15|2|(2)
0
0||
|||~~431~~
~~0~~
~~38~~||
|~~Net movement in funds~~|~~(393)~~||~~829~~
~~555~~
~~(47)~~
~~1337~~|
||||~~,~~|
||||14,296
1,200
47
15,543|
|~~Reconciliation of Funds:~~||||
|Total funds brought forward 1 April
21|15,125|1,755
0
16,880||
||||15,125
1,755
0
16,880|
|Total funds carried forward 31 March|14,732|2,186
0
16,918||
Notes 1 to 23 form part of these financial statements.
|Note
Unrestricted
Funds
£000
Restricted
Funds
£000
Endowment
Funds
£000
Total at 31
March 2025
£000
Fixed Assets
Investments
12
14,507
1,715
0
16,222
Intangible Fixed Assets
14
0
0
0
0
Other Tangible Fixed Assets
0
0
0
0
Total Fixed Assets
14,507
1,715
0
16,222
Current Assets
|Unrestricted
Funds
£000
Restricted
Funds
£000
Endowment
Funds
£000
Total at 31st
March 2024
£000|
|---|---|
||16,520
1,782
0
18,302
14
0
0
14
1
0
0
1|
||16,535
1,782
0
18,317|
|||
|~~Debtors~~
~~16~~
~~329~~
~~471~~
~~0~~
~~800~~
Short term Investments
13
2,635
2,161
0
4,796
Cash at bank and in hand
662
230
0
892|~~184~~
~~127~~
~~0~~
~~311~~
1,530
2,104
0
3,634
841
142
0
983|
|||
|Total Current Assets
3,626
2,862
0
6,488
Liabilities
Creditors: Amounts fallingdue within
17
3,293
2,391
0
5,684|2,555
2,373
0
4,928|
||3,608
373
0
3,981|
|~~one year~~||
|Total Current Liabilities
3,293
2,391
0
5,684
|3,608
373
0
3,981|
|||
|||
|~~Net Current Assets/(Liabilities)~~
~~333~~
~~471~~
~~0~~
~~804~~|~~(1,053)~~
~~2,000~~
~~0~~
~~947~~|
|||
|Total Assets less Current Liabilities
14,840
2,186
0
17,026|15,482
3,782
0
19,264|
|||
|~~Creditors: Amounts fallin due after more~~
~~17~~
~~108~~
~~0~~
~~0~~
~~108~~|~~357~~
~~2027~~
~~0~~
~~2384~~|
|~~g~~
than one year
|~~,~~
~~,~~|
|||
|Total Net Assets
14,732
2,186
0
16,918|15,125
1,755
0
16,880|
|Funds of the Charity
21
Restricted
2,186
2,186|1,755
1,755|
|Unrestricted
14,732
14,732|15,125
15,125|
|Total Funds
14,732
2,186
0
16,918||
||15,125
1,755
0
16,880|
The accompanying notes are an integral part of the financial statements. The financial statements on pages 48 to 61 were approved by the Board of Trustees on 02/09/2025 and signed on its behalf by:
Signed:
Name: Carole Ayre
Date: 02/09/2025
48
49
Statement of Cash Flows
## Notes to the financial statements
## for the year ending 31 March 2025
|Note
Net (expenditure)/income for the year (as per statement of fnancial activities)
Adjustments for:
Depreciation charges
(Gains)/Losses on investment portfolio
Investment management charges paid through capital
Dividends and interest on investments
(Increase)/decrease in debtors
Increase/(decrease) in creditors
Net cash provided by (used in) operating activities
Cash fows from investing activities
Dividends and interest on investments (inc Short term investments)
Proceeds from sale of investments
Purchase of investments
(Increase)/decrease in short term investments
Gains relating to short-term investments
Net cash provided by investing activities
Change in cash and cash equivalents in the year
23
Cash and cash equivalents brought forward
Cash and cash equivalents carried forward|Total
Funds
2024/25
£000
Total
Funds
2023/24
£000
38
1,337
15
14
(110)
(981)
96
94
(468)
(548)
(489)
(121)
(573)
(142)|
|---|---|
||(1,491)
(347)|
||468
548
10,710
8,379
(8,711)
(9,095)
(1,162)
(38)
95
0|
||1,400
(206)|
||(91)
(553)
983
1,536|
||892
983|
Notes 1 to 23 form part of these financial statements.
## for the period ended 31 March 2025
## 1 Company information
Nottingham University Hospitals Charity (charity number 1165397) is incorporated in England and Wales as a company limited by guarantee not having a share capital. The address of its registered office is City Hospital, 2 Embley Road, North Road, Nottingham, NG5 1RE.
Nottingham University Hospitals Charity operates with the objective of raising money to further such charitable purposes as:
- Funding local research and innovation
- Investing in whole-hospital staff development projects
- Purchasing the newest technology
- Creating a caring environment for all who use Nottingham’s hospitals
## 1.1 Accounting Policies
The following accounting policies have been applied consistently for all years in dealing with items that are considered material in relation to the financial statements of the charity.
## 1.2 Basis of preparation
The financial statements have been prepared on a going concern basis as a public benefit charity, under the historical cost convention, as modified for the revaluation of certain investments which are included at market value, and in accordance with the Statement of Recommended Practice: Accounting and Reporting by Charities (Charities SORP [FRS102]), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) and the Companies Act 2006.
## 1.3 Going Concern
The Charity’s cash balances and unrestricted reserves position are sufficient to absorb short-term deficits if required.
The Trustees consider that there are no material uncertainties regarding the charity’s ability to continue as a going concern. With respect to the next reporting period, 2025/26, the most significant area of uncertainty that affects the carrying value of assets held by the Charity is the performance of investment markets (see the ‘investment policy’ and ‘managing risks’ sections of the Annual Report for more information).
The financial forecasts prepared by the executive team show that the Charity will be able to operate with the resources available to it and for this reason, the Trustees continue to adopt the going concern basis in preparing the accounts.
## 1.4 Income recognition
All incoming resources are included in full in the Statement of Financial Activities as soon as the following three factors are met:
- i) entitlement – when control over the rights or other access to the economic benefit has passed to the Charity
- ii) probable – it is more likely than not that the economic benefit associated with the transaction or gift will flow to the Charity
- iii) measurement – the monetary value or amount of income can be measured reliably, and the costs incurred to complete the transaction can be measured reliably
## a. Legacies
Receipt of a legacy is recognised when it is probable that it will be received. Receipt is normally probable when there has been grant of probate; the executors have established that there are sufficient funds in the estate, after settling any liabilities, to pay the legacy and any conditions attached to the legacy are either within the control of the Charity or have been met.
## b. Income from investments
Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the Charity; this is normally upon notification of the interest paid or payable by the bank. Other investment income is recognised once notification has been received of the income due.
## c. Income from trading activities
Includes income from fundraising events and trading activities to raise funds for the Charity. Income is exchanged for supplying goods and services in order to raise funds and is recognised when entitlement has occurred.
## d. Gifts in kind
- i) Assets given for distribution by the Charity are included in the Statement of Financial Activities only when distributed.
- ii) Assets given for use by the funds (e.g. property for its own occupation) are included in the Statement of Financial Activities as incoming resources when receivable.
- iii) Gifts made in kind but on trust for conversion into cash and subsequent applications by the funds are included in the accounting period in which the gift is sold.
In all cases the amount at which gifts are brought into account is either a reasonable estimate of their value to the Charity or the amount actually realised. The basis of the valuation is disclosed in the Annual Report.
There were no gifts in kind included in income and expenditure during 2024/25.
## 1.5 Expenditure recognition
The accounts are prepared in accordance with the accruals concept. All expenditure is recognised once there is a legal or constructive obligation to make a payment to a third party.
The Charity is not registered for VAT and irrecoverable VAT is charged against the category of resources expended for which it was incurred.
## a. Costs of raising funds
The costs of raising funds are the costs associated with generating income for the funds held on trust. This will include the cost associated with fundraising and communications and investment management. A 10% charge is allocated to funds based on income received during the year.
50
51
## b. Grants payable
All liabilities and constructive obligations are recognised in the Statement of Financial Activities in the year in which approval is given by Trustees, regardless of the due date for payment. Grants payable are payments made to third parties (including NHS bodies) in the furtherance of the charitable objectives of the Charity i.e. “any charitable purpose or purposes relating to the general or any specific purposes of the Nottingham University Hospitals NHS Trust or any purposes relating to the NHS”. These are included under Charitable Activities in the Statement of Financial Activities.
## c. Charitable Activities
Costs of charitable activities comprise all costs identified as wholly or mainly incurred in the pursuit of the charitable objectives of the charity. These costs are direct costs together with an apportionment of governance and support costs as shown in note 8.
## d. Governance and Support Costs
Governance costs comprise all costs identifiable as wholly or mainly attributable to ensuring the public accountability of the Charity and its compliance with regulation and good practice. These costs include costs related to statutory audit and legal fees. Support costs are the administrative costs of awarding, monitoring and assessing grants, and the running costs of the Charity. Both governance and support costs have been allocated to Charitable Activities in accordance with Charities SORP (FRS102) on the basis of value of grants issued. Note 7 shows the list of these costs over the different headings. Note 8 shows the governance and support costs allocated to the different Charitable Activities on the basis of value of grants awarded within each category. A 2% charge is allocated to funds on the basis of closing balance.
## 1.6 Structure of funds
## a. Restricted Funds
Where there is a legal restriction imposed by donors on the purpose to which a fund may be used, the fund is classified in the accounts as a restricted fund. Descriptions of these funds are provided in note 21. Income and expenditure is shown separately within the Statement of Financial Activities and analysed into their component parts in note 21.1.
## b. Endowment Funds
Following the re-designation of the Nottingham Children’s Samaritan Fund in 2023/24. There are currently no endowment funds.
## c. Unrestricted/Designated Funds
Unrestricted funds are available for use at the discretion of Trustees. In cases where the non-binding wishes of a donor are known or where the Trustees, at their discretion, have created a specific fund for a specific purpose, designated funds have been established. Income and expenditure is shown separately within the Statement of Financial Activities and analysed into their component parts in note 21.2.
## 1.7 Fixed Assets
## a. Capitalisation
All assets falling into the following categories are capitalised: i) tangible assets which are capable of being used for more than one year, and have a cost equal to or greater than £5,000;
ii) groups of assets which are capable of being used for more than one year, and have a cost equal to or greater than £5,000;
iii) computer software licences are capitalised as intangible assets where they are capable of being used for more than one year and have a cost, individually or as a group, equal to or greater than £5,000.
## b. Valuation
- i) Tangible fixed assets are stated at cost less depreciation. ii) Intangible fixed assets held for operational use are valued at historical cost less depreciation.
## c. Investments
Fixed and current asset investments consist of long-term and short-term investments that are recognised as:
- i) Quoted stocks and shares are included in the balance sheet at market value at the balance sheet date.
- ii) Cash investments are held at cost plus accrued interest.
## 1.8 Financial Instruments
The charity has chosen to adopt Section 11 of FRS 102 in respect of financial instruments.
## 1.9 Realised gains and losses
All gains and losses are taken to the Statement of Financial Activities as they arise. Realised gains and losses on investments are calculated as the difference between sales proceeds and opening market value (or date of purchase if later). Unrealised gains and losses are calculated as the difference between market value at the year end and opening market value (or date of purchase if later). 20% of gains or losses in year are allocated to funds on the basis of closing balance.
## 1.10 Current Assets and Liabilities
- a. Assets and Liabilities are recognised at the amount receivable or payable including any related transaction costs.
- b. Cash at bank and in hand includes cash and short term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.
- c. Stocks are stated at the lower of cost and estimated selling price less costs to complete to sell.
## 1.11 Leases
Leases that do not transfer all the risks and rewards of ownership are classified as operating leases. Payments under operating leases are charged to the SoFA on a straight line basis over the period of the lease.
Lease costs are shown in note 22.
## 1.12 Pension Contributions
The Charity operates two pension schemes, a defined benefit scheme for employees TUPED from Nottingham University Hospitals NHS Trust on 1 April 2018 and a defined contribution scheme for employees employed directly by the Charity since 1 April 2013.
Details of the NHS Pension scheme can be found at www. nhsbsa.nhs.uk/pensions. The scheme is not designed to be operated in a way that would enable the Charity to identify its share of the underlying scheme assets and liabilities. Therefore, the scheme is accounted for as if it were a defined contribution scheme: the cost of participating in the scheme is taken as equal to the contributions payable to the scheme for the accounting period.
Members of the NHS Pension scheme contributed between 8.3% and 12.5% in 2024/25 while the employer contribution rate is 14.38% of pensionable pay.
The defined contribution scheme is the National Employment Savings Trust (NEST), a government workplace pension scheme with phased minimum employee and employer contributions based on basic pay.
The cost of the employer pension contributions to the NHS Pension Scheme and NEST are charged, along with other governance and support costs (as analysed at notes 6 and 7) to the Statement of Financial Activities under the headings Charitable Activities and Governance and Support Costs. A breakdown of staff costs can be seen in Note 10.
## 1.13 Related Party Transactions and Trustees’ Expenses and Remuneration
Patients of Nottingham University Hospitals NHS Trust (NUH Trust) are the main beneficiaries of the Charity. The Charity has made grants to NUH Trust and these are detailed in note 9.
None of the trustees or parties related to them have received remuneration or received any other benefits from employment with the Charity. The trustees have purchased indemnity insurance at a cost of £7,334 for £5 million of cover (2023/24: £7,021).
During the year ended 31 March 2025, trustees have received no reimbursements for expenses or other related costs (2023/24: £0).
## 1.14 Accounting Judgements and Key Sources of Estimation Uncertainty
In the application of the Charity’s accounting policies, which are described in note 1, the Trustees are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
The Trustees do not consider there are any critical judgements or sources of estimation uncertainty requiring disclosure beyond the accounting policies listed.
52
53
## 2. Analysis of Income from Legacies and Donations
|2. Analysis of Income from Legacies and Donations||
|---|---|
|Unrestricted
Funds
£000
Restricted
Funds
£000
Endowment
Funds
£000
Total
2024/25
Funds
£000
Legacies
717
1,642
0
2,359
General Donations
894
279
0
1,173|Unrestricted
Funds
£000
Restricted
Funds
£000
Endowment
Funds
£000
Total
2023/24
Funds
£000
425
562
0
987
1,628
221
0
1,849|
|Total
1,611
1,921
0
3,532|2,053
783
0
2,836|
## 3. Income from Charitable Activities
This category includes income from charitable activities representing contractual payments from other organisations to fund the provision of services.
## 4. Analysis of Income from Other Trading Activities
This category includes income from trading activities including income earned to raise funds for the Charity from fundraising events under the management of the Charity, sponsorship and the sale of goods.
||
|
|
|---|---|---|
|Fundraising Events
Lottery
Total|Unrestricted
Funds
£000
Restricted
Funds
£000
Endowment
Funds
£000
Total
2024/25
Funds
£000
190
0
0
190
19
0
0
19|Unrestricted
Funds
£000
Restricted
Funds
£000
Endowment
Funds
£000
Total
2023/24
Funds
£000
138
0
0
138
4
0
0
4|
||209
0
0
209|142
0
0
142|
The lottery is undertaken by an external lottery manager, the gross income being shown above.
Our general volunteers represent the Charity as part of our community fundraising team at fundraising and local events. General volunteer time is not recognised in the accounts.
5. Analysis of gross income from investments (including short term investments)
|(including short term investments)|||
|---|---|---|
|Gross income from investments|Held
in UK
£000
Held
outside UK
£000
378
90|2024/25
Total
£000
Held
in UK
£000
Held
outside UK
£000
2023/24
Total
£000
468
491
57
548|
||378
90|468
491
57
548|
## 6. Analysis of Expenditure on Raising Funds
|6. Analysis of Expenditure on Raising Funds||
|---|---|
|Fundraising Salaries
Fundraising Expenses
Investment Management Fees|Total costs
2024/25
£000
Total costs
2023/24
£000
428
593
224
199
96
94|
||748
886|
Costs of raising funds are incurred to generate all voluntary income for the Charity, including legacies and donations, as included in note 2.
## 7. Allocation of Governance and Support Costs
An explanation as to the allocation of support and governance costs to the following categories can be found in the notes to the accounts, reference 1.5(d).
|the notes to the accounts, reference 1.5(d).||
|---|---|
|Governance Costs
Salaries & associated costs
Audit Fees (Internal and external)
Legal
Other Governance Costs
Finance and Support Costs
Salaries & associated costs
Information Technology and licence costs
Other Support Costs
Total Governance and Support|2024/25
Total
£000
2023/24
Total
£000
103
108
20
15
7
4
29
27|
||159
154|
||251
245
39
59
75
88|
||365
392|
|||
||524
546|
## 8. Analysis of Charitable Expenditure
|Patients welfare and facilities
Staff welfare and development
Research
Building and refurbishment|Grants
£000
Direct
Delivery
£000
Support
costs
£000
Total
2024/25
£000
Grants
£000
Activities
Undertaken
Directly
£000
Support
costs
£000
Total
2023/24
£000
2,255
22
395
2,672
1,229
0
386
1,615
250
0
44
294
310
0
97
407
288
0
51
339
83
0
26
109
194
0
34
228
116
0
36
152|
|---|---|
||2,987
22
524
3,533
1,738
0
546
2,284|
Each restricted fund is charged a contribution towards support and governance costs as a proportion of total funds held, in recognition that these costs are incurred in respect of all funds. In 2024/25 this charge was £75,958 (2023/24: £49,040).
## 9. Analysis of Grants to Institutions
The Charity has approved grants to institutions, as follows:
|9. Analysis of Grants to Institutions
The Charity has approved grants to institutions, as follows:||
|---|---|
|Name of Institution
Nottingham University Hospitals NHS Trust
University of Nottingham
Total
10. Analysis of staff costs
Salaries and wages
National Insurance
Other pension costs
Total staff costs
The head count of staff in the year was:
Average Full Time Equivalent|2024/25
£000
2023/24
£000
2,846
1,689
141
49|
||2,987
1,738|
||Total
2024/25
£000
Total
2023/24
£000
693
812
66
74
45
60|
||804
946|
|||
||19
22|
|||
||17
20|
Staff costs include amounts reported under Note 6 (Raising Funds) and Note 7 (Allocation of Governance and Support). The remaining £21,916, relating to volunteer management, is reported under Charitable Activities – Direct Delivery.
54
55
## 10.1 Senior Employees
The key management personnel of the Charity comprise the Trustees, the Chief Executive Officer, Finance Director and Director of Fundraising and Communications. The Trustees were not paid and did not receive any other benefits from employment with the Charity. The total employee benefits of key management of the Charity including employer pension contributions were £242,598 (2023/24: £321,932).
Senior Management bandings (benefits, excluding pension contributions) as follows:
||2024/25|2023/24|
|---|---|---|
|£60,000 – £69,999|0|0|
|£70,000 – £79,999|1|1|
|£80,000 – £89,999|0|1|
|£90,000 – £99,999|1|0|
|£100,000 – £110,000|0|1|
Employer’s pension costs for these employees amount to £16,388 (2023/24: £30,130).
## 11. Auditors’ remuneration
Total external audit fees for Cooper Parry in respect of statutory audit are £15,420 inclusive of VAT, which represents the auditor’s remuneration for 2024/25 (2023/24: £14,700).
## 12. Fixed Asset Investment
|12. Fixed Asset Investment|||
|---|---|---|
|Movement in fxed asset investments:
Market value brought forward
Add: Acquisitions at cost
Less: Disposals at carrying value
Net gain/(loss) on revaluation
Investment fees paid against capital
Market value at 31 March 2025
Market value at 31 March :
Investments listed on Stock Exchange
Other UK fxed interest
Index Linked
Investments in Common Investment Fund
Cash held as part of the investment portfolio
Currency Funds
Other investments
Accrual: investment management fee held against capital|Investments
£000
Cash Held
£000
Total
£000
18,099
203
18,302
8,199
512
8,711
(10,710)
0
(10,710)
15
0
15
(96)
0
(96)
15,507
715
16,222
Held
in UK
£000
Held
outside UK
£000
2025
Total
£000
2024
Total
£000
559
1,511
2,070
1,727
1,477
0
1,477
2,124
0
0
0
0
10,213
1,756
11,969
14,241
715
0
715
203
0
0
0
0
0
14
14
31
(23)
0
(23)
(24)|Investments
£000
Cash Held
£000
Total
£000
18,099
203
18,302
8,199
512
8,711
(10,710)
0
(10,710)
15
0
15
(96)
0
(96)|
|||15,507
715
16,222|
||12,941
3,281
16,222
18,302||
At 31 March 2025 investment management fees of £23,132 were outstanding against fixed asset investments, giving total charges for the year of £95,884 (2023/24: £94,144).
## 14. Intangible/Tangible Fixed Assets
Intangible fixed assets include an IT System which is held at cost less accumulated amortisation based on estimated useful economic life.
|estimated useful economic life.||
|---|---|
|Cost
Balance at 1 April 2024
Additions
Disposals
Balance at 31 March 2025
Accumulated depreciation
Balance at 1 April 2024
Charge for the year
Balance at 31 March 2025
Net Book Value 31 March 2025
Net Book Value 31 March 2024|Assets under
construction
£000
Other Intangible
Fixed Assets
£000
Total Intangible
Fixed Assets
£000
0
71
71
0
0
0
0
0
0|
||0
71
71|
||0
57
57
0
14
14|
||0
71
71|
|||
||0
0
0|
|||
||0
14
14|
In addition, tangible fixed assets (computer equipment) acquired in 2020/21 at a cost of £5,976 has been fully depreciated. The value of the depreciation charge in 2024/25 was £1,195.
## 15. Transfers between funds
|15. Transfers between funds||
|---|---|
|To correct a transfer of gains to the restricted revaluation reserve in the 2023/24
accounts/returned to unrestricted funds.
Funding transferred to restricted funds to support overdrawn restricted projects|Unrestricted
Funds
£000
Restricted
Funds
£000
Endowment
Funds
£000
Total
Transfer
2024/25
13
(13)
0
0
(11)
11
0
0|
||2
(2)
0
0|
Transfers arise where a contribution is made by one fund towards the income or expenditure of another or where there is the transfer of a balance to another fund so that it follows the service to which it relates.
## 16. Analysis of Debtors
|16. Analysis of Debtors||
|---|---|
|At 31 March
Debtors falling due within one year:
Prepayments
Accrued income
Total debtors falling due within one year|2025
£000
2024
£000
16
42
784
269|
||800
311|
No debtors were due after more than one year at either 31 March 2025 or 31 March 2024.
Total investment gains for the year were £110,048, comprising £94,581 from short-term investments and £15,467 from fixed asset investments, as noted above.
## 13. Short Term Investments
This category includes cash on deposit and cash equivalents with a maturity of less than one year held for investment purposes. The value of short term investments at 31st March 2025 was £4,796,574 (2023/24: £3,633,886).
56
57
## 17. Analysis of Creditors
|17. Analysis of Creditors||
|---|---|
|At 31 March
Amounts falling due within one year:
Grant Accruals (note 17.1)
Deferred income
Taxation and Social Security
Other creditors
Total creditors falling due within one year
Amounts falling due after more than one year:
Grant Accruals (note 17.1)
Deferred income
Total creditors falling due after more than one year|2025
£000
2024
£000
3,481
3,864
100
0
18
25
2,085
92|
||5,684
3,981|
||108
384
0
2,000|
||108
2,384|
Other creditors includes a grant of £2 million received for the Helipad at QMC. Due to the delay of Tomorrow’s NUH until 2038 it has been agreed that this grant will be returned during 2025/26. As a consequence, the grant was previously classified as deferred income and has been re-classified under creditors.
At 31 March 2025, deferred income includes a restricted donation of £100,000 which was subject to NHS Trust project approval. This approval had not been obtained at the year-end and therefore the income has been deferred in line with the Charity’s income recognition policy. Approval was subsequently granted in July 2025 and the donation will be recognised as income in the 2025/26 financial year.
## 17.1 Analysis of grant accruals
|17.1 Analysis of grant accruals||
|---|---|
|At 31 March
Outstanding grant accruals brought forward
Additions during the period
Amounts charged against the accrual
Adjustments in the period
Outstanding grant accruals at 31 March 2025
Amounts falling due within one year
Amounts falling due after more than one year
Outstanding grant accruals at 31 March 2025|2025
£000
2024
£000
4,248
5,030
3,675
2,252
(3,571)
(2,801)
(763)
(233)|
||3,589
4,248|
||3,481
3,864
108
384|
||3,589
4,248|
## 18. Provisions for liabilities and charges
There are no grants payable whose values require subjective estimation and therefore no provisions have been included in this set of accounts. Note 1.5(b) refers to the accounting treatment of charity grants.
## 19. Contingent Liabilities
The following items relate to charitable grants where Trustees had not given formal approval at the balance sheet date. These grants have therefore not been recognised in the accounts:
## 20. Loans and guarantees
There are no loans or guarantees secured against the assets of the Charity.
## 21. Analysis of Charitable Funds
|21. Analysis of Charitable Funds||
|---|---|
|1. Restricted Funds
Material Funds: Name of Fund
Motor Neurone Disease Research
Myeloma Research Fellowship
Nottingham Children’s Samaritan Fund
Gynae-Oncology Research
Cardiac Services
Clinical Haematology
Amanda Lee Coppel Fund
Restricted Revaluation Fund
Better Security Better Care
Neurology Research
Critical Care Fund
Robotic Surgery Fund
Children’s Audiology Fund
Others (22)
Total
Restricted Funds-Prior Year
Material Funds: Name of Fund
Motor Neurone Disease Research
Myeloma Research Fellowship
Nottingham Children’s Samaritan Fund
Palliative Care Fund
Gynae-Oncology Research
Cardiac Services
Clinical Haematology
Amanda Lee Coppel Fund
Restricted Revaluation Fund
Better Security Better Care
Neurology Research
Others (17)
Total|Balance
31 March
2024
Income
Expenditure
Transfers
Gains and
Losses
Balance
31 March
2025
£000
£000
£000
£000
£000
£000
250
8
(13)
0
0
245
155
4
(6)
0
0
153
114
0
(13)
0
0
101
47
1
(2)
0
0
46
101
13
(6)
0
0
108
117
3
(4)
6
0
122
240
7
(25)
0
0
222
198
0
(11)
(13)
12
186
2
152
(154)
0
0
0
268
52
(18)
0
0
302
0
194
(5)
0
0
189
0
1,100
(1,100)
0
0
0
0
212
0
0
0
212
263
220
(188)
5
0
300|
||1,755
1,966
(1,545)
(2)
12
2,186|
||Balance
31 March
2023
Income
Expenditure
Transfers
Gains and
Losses
Balance
31 March
2024
£000
£000
£000
£000
£000
£000
256
6
(11)
(4)
3
250
157
4
(6)
(2)
2
155
75
0
(8)
47
0
114
51
63
(114)
0
0
0
48
1
(2)
(1)
1
47
10
102
(13)
0
2
101
100
19
(3)
0
1
117
248
5
(12)
(4)
3
240
96
0
(11)
13
100
198
0
148
(148)
0
2
2
0
300
(36)
0
4
268
159
158
(50)
(4)
0
263|
||1,200
806
(414)
45
118
1,755|
|sheet date. These grants have therefore not been recognised in the accounts:||
|---|---|
|Pump-priming grants from General Research Funds
Total|2024/25
£000
2023/24
£000
174
98|
||174
98|
58
59
## 21. Analysis of Charitable Funds (cont.)
Detail of Material Restricted Funds
|Name of fund|Description of the nature and purpose of each fund|
|---|---|
|Motor Neurone Research|A legacy fund to support research into Motor Neurone Disease.|
|Myeloma Research Fellowship|A legacy fund established for a fellowship called the Stanley & Marion Irish Nee Bethell fellowship for support of|
||multiple myeloma research in the Academic Department of Haematology.|
|Nottingham Children’s Samaritan Fund|For the beneft of needy children who are patients or recently discharged patients of any hospital administered|
||within the Nottingham Health District or needy children who reside in or near the City of Nottingham but who are|
||receiving treatment elsewhere.|
|Gynae-Oncology Research|A legacy fund to support care and treatment for Gynae-Oncology patients.|
|Cardiac Services|A legacy fund to provide cardiac care including equipment and research.|
|Clinical Haematology|A legacy fund to support care, treatment and research for Clinical Haematology patients.|
|Amanda Lee Coppel Fund|For the beneft of special needs children and young adults who are NHS patients within Nottinghamshire.|
|Restricted Revaluation Fund|Accumulated Revaluation Fund in relation to restricted funds.|
|Better Security Better Care|A restricted fund to support a dedicated IT project at NUH and in Social Care.|
|Neurology Research|A legacy fund to support research into Myotonic Dystrophy.|
|Critical Care Fund|A legacy fund to support research into Critical Care at the City Hospital.|
|Robotic Surgery|A discretionary legacy from the late Wing Commander John Rogers to support robotic surgery equipment.|
|Children’s Audiology Fund|A legacy fund to support the Children’s Cochlear Implant Team|
## 2. Unrestricted Funds
|Detail of Material Unrestricted Funds-Prior Year
Designated Funds
Breast Fund
Children’s Hospital including Big Appeal
Lead Appeal Gift Fund
Nephrology Research Fund
Palliative Care
Research General
Staff Development Fund
Stroke Services
Revaluation Fund
Other designated funds (145)
Total designated funds
Reserves
General Funds (including Directorate Support and NUH Development)
Total designated funds
Total unrestricted funds|Balance
31 March
2023
£000
Income
£000
Expenditure
£000
Transfers
£000
Gains and
Losses
£000
Balance
31 March
2024
£000
616
93
(185)
(11)
7
520
1,396
250
(394)
(13)
17
1,256
628
22
(35)
(30)
8
593
469
19
(26)
0
6
468
1,724
388
(482)
0
26
1,656
424
860
(161)
0
16
1,139
539
14
(175)
0
5
383
383
26
(38)
0
6
377
1,667
0
(83)
(1)
677
2,260
5,060
776
(895)
(10)
74
5,005|
|---|---|
||12,906
2,448
(2,474)
(65)
842
13,657|
||1,390
272
(281)
66
21
1,468|
||1,390
272
(281)
66
21
1,468|
|||
||14,296
2,720
(2,755)
1
863
15,125|
Funds with an opening or closing balance in excess of 3% of total unrestricted funds are classified as material.
## 3. Unrestricted Funds
Detail of Material Unrestricted Funds
## Detail of Material Unrestricted Funds
The following funds are held to support general or research projects within the designated division or specialty:
|division or specialty:||
|---|---|
|Designated Funds
Breast Fund
Children’s Hospital including Big Appeal
Lead Appeal Gift Fund
Nephrology Research Fund
Palliative Care
Research General
Staff Development Fund
Stroke Services
Revaluation Fund
Other designated funds (131)
Total designated funds
Reserves
General Funds (including Directorate Support and NUH Development)
Total Reserves
Total unrestricted funds|Balance
31 March
2024
£000
Income
£000
Expenditure
£000
Transfers
£000
Gains and
Losses
£000
Balance
31 March
2025
£000
520
34
(17)
0
0
537
1,256
251
(667)
0
0
840
593
0
0
0
0
593
468
0
(33)
0
0
435
1,656
343
(503)
0
0
1,496
1,139
26
(138)
0
0
1,027
383
0
(70)
0
0
313
377
9
(143)
0
0
243
2,260
0
(85)
13
98
2,286
5,005
1,165
(943)
(8)
0
5,219|
||13,657
1,828
(2,599)
5
98
12,989|
||1,468
415
(137)
(3)
0
1,743|
||1,468
415
(137)
(3)
0
1,743|
|||
||15,125
2,243
(2,736)
2
98
14,732|
|Name of fund
Description of the nature and purpose of each fund|Name of fund
Description of the nature and purpose of each fund|Name of fund
Description of the nature and purpose of each fund|
|---|---|---|
|Breast Fund
Designated fund to support Breast Services at Nottingham University Hospitals Trust (NUHT).
Children’s Hospital including Big Appeal
Designated appeal fund to support Nottingham Children’s Hospital.
Lead Appeal Gift Fund
Designated fund to support Charity major appeals.
Nephrology Research Fund
Designated fund to support Nephrology Research at NUHT.
Palliative Care
Designated fund to support Palliative Care and Hayward House at NUHT.
Research General
These funds comprise the NUH Medical Research Fund and the Cancer General Research Fund. The NUH Medical
Research Fund was formerly known as the Research General Fund, which was renamed following a signifcant
donation from the Nottingham City Hospital Medical Research Trust during 2023/24.
Staff Development Fund
Designated fund to support staff development related projects at NUHT.
Stroke Services
Designated fund to support Stroke Services at NUHT.
Revaluation Fund
Accumulated Revaluation Fund.
NUH Development
Unrestricted fund to support innovation projects at NUHT.
Directorate Support
Unrestricted fund to provide support for cross hospital projects.
22. Leasing Commitments
The Charity’s future minimum operating lease payments are as follows:
Within one year
2024/25
£000
2023/24
£000
5
5
23. Analysis of changes in net debt
At
01 April
2024
£000
Cash fows
£000
Other
Changes
£000
At
31 March
2025
£000
Cash at bank and in hand
983
(91)
0
892
983
(91)
0
892|||
|||Other
Changes
£000
At
31 March
2025
£000
0
892|
||983
(91)|0
892|
60
61
Reference and administrative details of the Charity
**----- Start of picture text -----**
62
**----- End of picture text -----**
**Charity name:** Nottingham University Hospitals Charity **Other names used:** Nottingham Hospitals Charity **Registered no:** 1165397 **Charity’s objects:** or the purposes of the health service
**Company registration no:** 9978675 **Registered office:** Nottingham University Hospitals Charity, 2 Embley Road, Nottingham NG5 1RE **Telephone:** 0115 962 7905 **E-mail:** hello@nottinghamhospitalscharity.org.uk **Web address:** www.nottinghamhospitalscharity.org.uk
## **Advisors**
## **Solicitors:**
**Bankers:**
National Westminster Bank PLC 16 South Parade Nottingham NG1 2JX
Browne Jacobson LLP Mowbray House Castle Meadow Road Nottingham NG2 1BJ
## **Investment managers:**
## **Auditors:**
Sarasin
Cooper Parry Group Limited Sky View Argosy Road East Midlands Airport Derby DE74 2SA
Juxon House, 100 St Paul's Churchyard, London EC4M 8BU
**63**
Nottingham University Hospitals Charity 2 Embley Road, Nottingham, NG5 1RE
Telephone: 0115 962 7905 Email: hello@nottinghamhospitalscharity.org.uk
Registered in England & Wales no. 1165397. Company Limited by Guarantee registered in England no. 9978675